A newly developed radiotheranostic pair, 68Ga/177Lu-NYM096, can identify tumors and effectively deliver targeted radiotherapy to patients with metastatic clear cell renal cell carcinoma (ccRCC).
Newly developed radiotheranostic pair identifies and treats renal tumors
- Post author:admin
- Post published:
- Post category:uncategorized